Other Information.
+Added: February 9, 2023, the Company issued a promissory note in an aggregate principal amount of $300,000 to an affiliate of the Company’s
+Added: Sponsor, in connection with the extension of the Company’s time to consummate an initial Business Combination from January 29,
+Added: 2023 to July 29, 2023.
+Added: This note bears no interest and are repayable in full upon the earlier of (a) the date of the consummation of
+Added: the Company’s initial Business Combination, or (b) the date of the liquidation of the Company.
+Added: An aggregate of $100,000 has been
+Added: deposited into the Company’s Trust Account to extend the Company’s time to consummate a Business Combination from January
+Added: 29, 2023 to March 29, 2023.
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
−Removed: Amendment No.
−Removed: 1 to Business Combination Agreement, dated September 6, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.
−Removed: and the Sellers named therein (holding in excess of 50% of Chijet’s outstanding shares) (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 12, 2022).
−Removed: Amendment No.
−Removed: 2 to Business Combination Agreement, dated September 16, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.
−Removed: and the Sellers named therein (holding in excess of 50% of Chijet’s outstanding shares).
−Removed: (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 20, 2022).
−Removed: Business Combination Agreement, dated July 12, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.
−Removed: and the Sellers named therein (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed on July 18, 2022).
−Removed: Support Agreement dated July 12, 2022, among Deep Medicine Acquisition Corp., Bright Vision Sponsor LLC, Chijet Inc.
−Removed: and Chijet Motor Company, Inc.
−Removed: (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on July 18, 2022).
−Removed: Form of Promissory Note issued on October 15, 2022.
−Removed: (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 20, 2022).
+Added: Amendment to the Second Amended and Restated Certificate of Incorporation.
+Added: (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 23, 2022).
+Added: Form of Promissory Note issued on February 9, 2023.
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
4 unchanged sentences
Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: Inline XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Schema Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Labels Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Presentation Linkbase Document
−Removed: Cover Page Interactive
−Removed: Certain of the exhibits,
−Removed: appendices, annexes and/or schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2).
−Removed: The Registrant
−Removed: agrees to furnish supplementally a copy of all omitted exhibits, annexes, appendices and schedules to the Securities and Exchange
−Removed: Commission upon its request.
−Removed: Filed herewith.
−Removed: Furnished herewith.
+Added: XBRL Instance Document
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
+Added: XBRL Taxonomy Extension Labels Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Page Interactive Data File.
accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
−Removed: DEEP MEDICINE ACQUISITION CORP.
−Removed: November 14, 2022
−Removed: Chief Executive Officer
−Removed: (Principal Executive Officer)
−Removed: November 14, 2022
−Removed: Chief Financial Officer
−Removed: (Principal Financial and Accounting Officer)
+Added: MEDICINE ACQUISITION CORP.
+Added: February 10, 2023
+Added: Executive Officer
+Added: Executive Officer)
+Added: February 10, 2023
+Added: Financial Officer
+Added: Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.